Lichen sclerosus et atrophicans, scleroderma en coup de sabre and Lyme borreliosis

  • Serena Bonin | sbonin@units.it University of Trieste, Italy.
  • Nicoletta Gubertini Department of Medical Sciences, University of Trieste, .
  • Giusto Trevisan Department of Medical Sciences, University of Trieste, .

Abstract

Lichen sclerosus et atrophicans (LSA) is a chronic, inflammatory skin disease of unknown etiology, characterized by atrophy. We report a case of LSA with frontoparietal distribution, mimicking scleroderma en coup de sabre, causing scarring alopecia. The case was associated with Borrelia infection. The lesion improved with 2 cycles of antibiotic therapy with ceftriaxone 2 gr /day i.v for 21 days associated with UVA-1 therapy and local and systemic vitamin E supply (400 mg 2x/day per os for 3 months). This case stresses the importance of identifying clinical manifestations associated with Lyme disease and the use of tissue PCR to detect borrelial DNA in patients with these lesions, but characterized by negative serology for Borrelia.

Downloads

Download data is not yet available.

Author Biography

Serena Bonin, University of Trieste
Department of Medica Sciences
Published
2011-09-28
Section
Case Reports
Keywords:
lichen sclerosus et atrophicans, frontoparietal distribution, Lyme borreliosis, PCR, Borrelia.
Statistics
Abstract views: 1201

PDF: 456
HTML: 2831
Share it
Bookmark and Share

PlumX Metrics

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

How to Cite
Bonin, S., Gubertini, N., & Trevisan, G. (2011). Lichen sclerosus et atrophicans, scleroderma en coup de sabre and Lyme borreliosis. Dermatology Reports, 3(2), e27. https://doi.org/10.4081/dr.2011.e27